All Stories

  1. An economic evaluation of tofacitinib for the treatment of moderately-to-severely active ulcerative colitis: modeling the cost of treatment strategies in the United States

    Article • Journal of Medical Economics, May 2019, Taylor & Francis

    Dr Jeffrey A Bourret, Arif S

  2. Nurse Practitioners in Rheumatology

    Article • Journal of the American Association of Nurse Practitioners, October 2017, Wiley

    Michele McKay, Arif S